Left ventricular thrombus ups risk of MACE, death
Patients with left ventricular thrombus (LVT) are at increased risk of major adverse cardiovascular events (MACE) and mortality, while those with total LVT regression, achieved through various anticoagulant regimens, have a lower mortality, according to a study.